Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Roche Holdings Ltd ADR GRENZACHERSTRASSE 124 BASEL V8 CH-4070 CHE

www.roche.com Employees: 103,249 P: 41-61-688-1111

Sector:

Medical

INDUSTRY GROUPING:

Large Cap Pharma

Description:

Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its operations through two segments ' Pharmaceuticals and Diagnostics.Pharmaceuticals: Key focus areas in this segment include Oncology, Virology, Inflammation, Metabolism and Neuroscience. Diagnostics: The Diagnostics Division operates in four segments ' Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics, and Roche Tissue Diagnostics. In September 2014, Roche acquired InterMune for $8.3 billion and added Esbriet to its portfolio. During the first quarter of 2018, Roche acquired Flatiron Health and Ignyta, Inc.

Key Statistics

Overview:

Market Capitalization, $K 329,165,696
Enterprise Value, $K 360,606,272
Shares Outstanding, K 6,370,538
Annual Sales, $ 70,874 M
Annual Net Income, $ 9,402 M
EBIT, $ 0 K
EBITDA, $ 19,129 M
60-Month Beta 0.46
% of Institutional Shareholders 0.00%
Float, K 6,370,538
% Float 100.00%
Short Interest 3,888
Short Float 0.06%
Short Volume Ratio 0.37

Growth:

1-Year Return 46.67%
3-Year Return 30.29%
5-Year Return 20.94%
5-Year Revenue Growth 10.46%
5-Year Earnings Growth 5.12%
5-Year Dividend Growth 25.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
Annual Dividend & Yield 0.87 (1.69%)
Annual Dividend & Yield (Fwd) 0.87 (1.68%)
Most Recent Dividend 0.873 on 03/28/25
Next Ex-Dividends Date 03/28/25
Dividend Payable Date 04/22/14
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 02/27/14

RHHBY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 17.61
Price/Earnings to Growth 3.35
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 13.27%
Debt/Equity 1.00
Price/Sales 4.80
Price/Cash Flow 15.68
Price/Book 8.24
Book Value/Share 6.29
Interest Coverage 9.35

RHHBY Dividends

Date Value
03/28/25 $0.8730
03/14/24 $0.8470
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar